5 High Growth Pharma Stocks that are Profitable

3. Precigen, Inc. (NASDAQ:PGEN)

Q/Q Sales Growth: 406%

Number of Hedge Fund Holders in Q3 2022: 17

Precigen, Inc. (NASDAQ:PGEN) is a biotechnology firm that focuses on genetic and cellular therapies. These involve combining genetic components for genetic expression and a gene that improves immune system performance. The firm is headquartered in Germantown, Maryland.

Precigen, Inc. (NASDAQ:PGEN)’s third quarter results saw the firm post $13.4 million in revenue, which, when compared to the year ago quarter’s $3.3 million in sales marked a 406% annual growth. Insider Monkey surveyed 920 hedge funds for the September quarter of 2022 investments to discover that 17 had held a stake in Precigen, Inc. (NASDAQ:PGEN).

Follow Precigen Inc. (NYSE:PGEN)